Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Integrin beta 1/CD29 Antibody (12G10), FITC, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NB10063255F

Catalog No. NB212468


Only null left
Add to Cart

Description

Description

Integrin beta 1/CD29 Monoclonal antibody specifically detects Integrin beta 1/CD29 in Human, Mustelid samples. It is validated for Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunohistochemistry (Frozen)
Specifications

Specifications

Integrin beta 1/CD29
Monoclonal
FITC
CD29, CD29 antigen, Fibronectin receptor subunit beta, FNRBVLAB, GPIIA, integrin beta-1, integrin VLA-4 beta subunit, integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includesMDF2, MSK12), MDF2, MSK12, very late activation protein, beta polypeptide, VLA-4 subunit beta, VLA-BETA
Purified human beta1 integrin preparation from HT1080 fibrosarcoma cell extract.
0.1 mL
Cancer, Cell Biology, Cellular Markers, Cytokine Research, Immunology, Mesenchymal Stem Cell Markers, Neuronal Cell Markers, Signal Transduction, Stem Cell Markers
3688
Store at 4°C in the dark.
IgG1
Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunohistochemistry (Frozen)
12G10
PBS
Mouse
Protein G purified
RUO
Primary
Human, Mustelid
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.